Learn about smoldering myeloma and the first treatment approved by the U.S. Food and Drug Administration to prevent its...
Cancer Today and the AACR are hosting a webinar on Feb. 16 at 1 p.m. EST. A panel of...
Patients have long benefited from combination treatments—whether combining surgery with chemotherapy and radiation, or combining chemotherapy agents in succession.
The FDA has approved expanding the use of the molecularly targeted therapeutic ibrutinib (Imbruvica) to include the treatment of...
A hot topic in the field of cancer immunotherapy is: How do some cancers that initially respond to immune...
The next step in trying to increase the proportion of patients who respond to these therapies, therefore, is to...
Guest Post by William G. Nelson, MD, PhD Editor-in-Chief, Cancer Today Over the past few years, scientists have come...
A team of researchers from Australia has shown that an optical fiber-tip probe that can detect the pH of...
January is Cervical Cancer Awareness Month. It’s a time to celebrate progress against a disease that was once a...
Experts identify opportunities and challenges facing cancer researchers in 2017.
AACR Project Genomics Evidence Neoplasia Information Exchange, or GENIE for short, has released one of the largest fully public...